ArticleOncoTargets and therapy2020

Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing.

Chenlu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.